CE29 - Chimie : analyse, théorie, modélisation

Separation and identification of isomeric metabolites integrated to mass spectrometry for the diagnosis of metabolic diseases – DMIRGNOSIS

Submission summary

The objectives of this project are twofold and range from fundamental understanding of the separation process of isomers using differential mobility spectrometry (DMS) hyphenated to tandem mass spectrometry (MS/MS) to developing robust methodologies for isomer identification and quantification for targeted metabolomics analyses. Our ambition is thus to bridge gap between development of gas phase physical chemists (partner 1) and clinical biology (partner 2).
Our idea is to couple three orthogonal techniques: DMS, MS/MS, and an isomer-selective ion fragmentation based on infrared absorption, which could be considered as a « selective multiple reaction monitoring » (IR-MRM) method. Proof of principle of the application of our DMS-MS/MS(IR) approach for the identification of metabolite isomers has been published in 2018. Current standard protocols based on the coupling of liquid chromatography to tandem mass-spectrometry (LC-MS/MS) have some drawbacks which could be overcome with DMS-MS/MS(IR): large volume of (toxic) solvents to be recycled, and the fact that only a set of molecules with comparable polarities can be isocratically separated. In adding, separation of relevant metabolites from isobaric and/or isomeric compounds is often difficult. Through systematic studies of sets of targeted metabolites, relevant for different MDs, we want to challenge the robustness of DMS.
Our analytical targets are biomarkers of metabolic diseases (MDs), which are life-threatening inherited metabolic defects that irremediably lead to significant organ dysfunctions (i.e. brain, liver, cardiac, kidney, muscle...). Two applications dedicated to MD diagnosis will be performed in order to address the topics of emergency in metabolic diagnosis and newborn screening from blood samples.

Project coordination

Philippe Maitre (Laboratoire de Chimie Physique)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

LCP Laboratoire de Chimie Physique
PROTECT Promoting Research Oriented Towards Early Cns Therapies
LYPSYS LYPSYS

Help of the ANR 211,817 euros
Beginning and duration of the scientific project: October 2019 - 24 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter